Copyright Reports & Markets. All rights reserved.

Global Glucagon Like Peptide 2 Receptor Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Glucagon Like Peptide 2 Receptor Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Glucagon Like Peptide 2 Receptor Market Size Growth Rate by Product
      • 1.4.2 FE-203799
      • 1.4.3 Glepaglutide
      • 1.4.4 GXG-8
      • 1.4.5 HM-15910
      • 1.4.6 Others
    • 1.5 Market by End User
      • 1.5.1 Global Glucagon Like Peptide 2 Receptor Market Size Growth Rate by End User
      • 1.5.2 Short Bowel Syndrome
      • 1.5.3 Diabetes
      • 1.5.4 Diarrhea
      • 1.5.5 Obesity
      • 1.5.6 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Glucagon Like Peptide 2 Receptor Market Size
      • 2.1.1 Global Glucagon Like Peptide 2 Receptor Revenue 2014-2025
      • 2.1.2 Global Glucagon Like Peptide 2 Receptor Sales 2014-2025
    • 2.2 Glucagon Like Peptide 2 Receptor Growth Rate by Regions
      • 2.2.1 Global Glucagon Like Peptide 2 Receptor Sales by Regions
      • 2.2.2 Global Glucagon Like Peptide 2 Receptor Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Glucagon Like Peptide 2 Receptor Sales by Manufacturers
      • 3.1.1 Glucagon Like Peptide 2 Receptor Sales by Manufacturers
      • 3.1.2 Glucagon Like Peptide 2 Receptor Sales Market Share by Manufacturers
      • 3.1.3 Global Glucagon Like Peptide 2 Receptor Market Concentration Ratio (CR5 and HHI)
    • 3.2 Glucagon Like Peptide 2 Receptor Revenue by Manufacturers
      • 3.2.1 Glucagon Like Peptide 2 Receptor Revenue by Manufacturers (2014-2019)
      • 3.2.2 Glucagon Like Peptide 2 Receptor Revenue Share by Manufacturers (2014-2019)
    • 3.3 Glucagon Like Peptide 2 Receptor Price by Manufacturers
    • 3.4 Glucagon Like Peptide 2 Receptor Manufacturing Base Distribution, Product Types
      • 3.4.1 Glucagon Like Peptide 2 Receptor Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Glucagon Like Peptide 2 Receptor Product Type
      • 3.4.3 Date of International Manufacturers Enter into Glucagon Like Peptide 2 Receptor Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Glucagon Like Peptide 2 Receptor Sales by Product
    • 4.2 Global Glucagon Like Peptide 2 Receptor Revenue by Product
    • 4.3 Glucagon Like Peptide 2 Receptor Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Glucagon Like Peptide 2 Receptor Breakdown Data by End User

    6 North America

    • 6.1 North America Glucagon Like Peptide 2 Receptor by Countries
      • 6.1.1 North America Glucagon Like Peptide 2 Receptor Sales by Countries
      • 6.1.2 North America Glucagon Like Peptide 2 Receptor Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Glucagon Like Peptide 2 Receptor by Product
    • 6.3 North America Glucagon Like Peptide 2 Receptor by End User

    7 Europe

    • 7.1 Europe Glucagon Like Peptide 2 Receptor by Countries
      • 7.1.1 Europe Glucagon Like Peptide 2 Receptor Sales by Countries
      • 7.1.2 Europe Glucagon Like Peptide 2 Receptor Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Glucagon Like Peptide 2 Receptor by Product
    • 7.3 Europe Glucagon Like Peptide 2 Receptor by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Glucagon Like Peptide 2 Receptor by Countries
      • 8.1.1 Asia Pacific Glucagon Like Peptide 2 Receptor Sales by Countries
      • 8.1.2 Asia Pacific Glucagon Like Peptide 2 Receptor Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Glucagon Like Peptide 2 Receptor by Product
    • 8.3 Asia Pacific Glucagon Like Peptide 2 Receptor by End User

    9 Central & South America

    • 9.1 Central & South America Glucagon Like Peptide 2 Receptor by Countries
      • 9.1.1 Central & South America Glucagon Like Peptide 2 Receptor Sales by Countries
      • 9.1.2 Central & South America Glucagon Like Peptide 2 Receptor Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Glucagon Like Peptide 2 Receptor by Product
    • 9.3 Central & South America Glucagon Like Peptide 2 Receptor by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Glucagon Like Peptide 2 Receptor by Countries
      • 10.1.1 Middle East and Africa Glucagon Like Peptide 2 Receptor Sales by Countries
      • 10.1.2 Middle East and Africa Glucagon Like Peptide 2 Receptor Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Glucagon Like Peptide 2 Receptor by Product
    • 10.3 Middle East and Africa Glucagon Like Peptide 2 Receptor by End User

    11 Company Profiles

    • 11.1 Hanmi Pharmaceuticals Co Ltd
      • 11.1.1 Hanmi Pharmaceuticals Co Ltd Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Products Offered
      • 11.1.5 Hanmi Pharmaceuticals Co Ltd Recent Development
    • 11.2 Naia Ltd
      • 11.2.1 Naia Ltd Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Naia Ltd Glucagon Like Peptide 2 Receptor Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Naia Ltd Glucagon Like Peptide 2 Receptor Products Offered
      • 11.2.5 Naia Ltd Recent Development
    • 11.3 Shire Plc
      • 11.3.1 Shire Plc Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Shire Plc Glucagon Like Peptide 2 Receptor Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Shire Plc Glucagon Like Peptide 2 Receptor Products Offered
      • 11.3.5 Shire Plc Recent Development
    • 11.4 Tasly Pharmaceutical Group Co Ltd
      • 11.4.1 Tasly Pharmaceutical Group Co Ltd Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Products Offered
      • 11.4.5 Tasly Pharmaceutical Group Co Ltd Recent Development
    • 11.5 Zealand Pharma AS
      • 11.5.1 Zealand Pharma AS Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Zealand Pharma AS Glucagon Like Peptide 2 Receptor Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Zealand Pharma AS Glucagon Like Peptide 2 Receptor Products Offered
      • 11.5.5 Zealand Pharma AS Recent Development

    12 Future Forecast

    • 12.1 Glucagon Like Peptide 2 Receptor Market Forecast by Regions
      • 12.1.1 Global Glucagon Like Peptide 2 Receptor Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Glucagon Like Peptide 2 Receptor Revenue Forecast by Regions 2019-2025
    • 12.2 Glucagon Like Peptide 2 Receptor Market Forecast by Product
      • 12.2.1 Global Glucagon Like Peptide 2 Receptor Sales Forecast by Product 2019-2025
      • 12.2.2 Global Glucagon Like Peptide 2 Receptor Revenue Forecast by Product 2019-2025
    • 12.3 Glucagon Like Peptide 2 Receptor Market Forecast by End User
    • 12.4 North America Glucagon Like Peptide 2 Receptor Forecast
    • 12.5 Europe Glucagon Like Peptide 2 Receptor Forecast
    • 12.6 Asia Pacific Glucagon Like Peptide 2 Receptor Forecast
    • 12.7 Central & South America Glucagon Like Peptide 2 Receptor Forecast
    • 12.8 Middle East and Africa Glucagon Like Peptide 2 Receptor Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Glucagon Like Peptide 2 Receptor Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Glucagon Like Peptide 2 Receptor market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Glucagon Like Peptide 2 Receptor market based on company, product type, end user and key regions.

      This report studies the global market size of Glucagon Like Peptide 2 Receptor in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Glucagon Like Peptide 2 Receptor in these regions.
      This research report categorizes the global Glucagon Like Peptide 2 Receptor market by top players/brands, region, type and end user. This report also studies the global Glucagon Like Peptide 2 Receptor market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Hanmi Pharmaceuticals Co Ltd
      Naia Ltd
      Shire Plc
      Tasly Pharmaceutical Group Co Ltd
      Zealand Pharma AS

      Market size by Product
      FE-203799
      Glepaglutide
      GXG-8
      HM-15910
      Others
      Market size by End User
      Short Bowel Syndrome
      Diabetes
      Diarrhea
      Obesity
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Glucagon Like Peptide 2 Receptor market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Glucagon Like Peptide 2 Receptor market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Glucagon Like Peptide 2 Receptor companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Glucagon Like Peptide 2 Receptor submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Glucagon Like Peptide 2 Receptor are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Glucagon Like Peptide 2 Receptor market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now